Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Psychol Med. 2018 Feb 12;48(15):2550–2561. doi: 10.1017/S0033291718000168

Table 3.

Cross-sectional association between vasomotor symptoms and odds of depressed mood at baseline

Vasomotor symptoms (VMS) n Case
(%)a
Crude
OR (95% CI)
Model 1b
OR (95% CI)
Model 2c
OR (95% CI)
Frequency of VMS in the past 12 months (ALSWH) 10242 27.4
  Never 4135 21.2 Reference Reference Reference
  Rarely 1696 25.4 1.26 (1.10–1.44) 1.24 (1.08–1.41) 1.22 (1.07–1.40)
  Sometimes 2758 31.6 1.71 (1.53–1.91) 1.64 (1.46–1.83) 1.61 (1.43–1.80)
  Often 1653 37.9 2.27 (2.00–2.57) 2.17 (1.90–2.47) 2.08 (1.83–2.38)
Severity of VMS in the past 12 months (NSHD, NCDS) 5022 40.2
  Never 1640 32.0 Reference Reference Reference
  Mild 568 28.0 0.83 (0.67–1.02) 0.85 (0.68–1.05) 0.84 (0.68–1.03)
  Moderate 1787 43.0 1.60 (1.39–1.85) 1.62 (1.40–1.87) 1.59 (1.38–1.84)
  Severe 1027 55.5 2.65 (2.26–3.12) 2.65 (2.24–3.14) 2.54 (2.14–3.02)
Frequency of VMS in the past 2 weeks (SWAN) 2336 13.9
  Never 1109 9.7 Reference Reference Reference
  Rarely 740 12.6 1.33 (0.99–1.79) 1.31 (0.97–1.76) 1.25 (0.92–1.69)
  Sometimes 193 24.4 2.98 (2.03–4.38) 2.95 (2.01–4.35) 2.62 (1.76–3.89)
  Often 294 26.2 3.29 (2.37–4.56) 3.38 (2.40–4.74) 3.11 (2.18–4.43)
Severity of VMS in the past 2 weeks (SMWHS, HOW, JMWHS, WHITEHALL) 3712 9.9
  Never 2068 4.2 Reference Reference Reference
  Mild 919 10.8 3.01 (2.21–4.09) 3.11 (2.28–4.25) 3.01 (2.20–4.11)
  Moderate 420 21.4 6.69 (4.85–9.23) 7.06 (5.06–9.83) 6.89 (4.93–9.64)
  Severe 305 29.8 10.1 (7.26–14.1) 10.5 (7.43–14.7) 9.79 (6.90–13.9)
Overall sample: VMS 21312 25.9
  Never 8952 17.8 Reference Reference Reference
  Rarely/mild 3923 19.9 1.25 (1.13–1.38) 1.25 (1.13–1.38) 1.23 (1.11–1.35)
  Sometimes/moderate 5158 34.4 1.90 (1.75–2.06) 1.87 (1.72–2.03) 1.82 (1.67–1.98)
  Often/severe 3279 41.6 2.78 (2.54–3.05) 2.71 (2.47–2.98) 2.59 (2.35–2.85)

Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (95% CI). Study level variability was adjusted by including study indicator as a covariate in the crude and multivariable model.

a

Depressed mood was defined by “often or sometimes” having depressed mood or having “severe or moderate” depressed mood.

b

Model 1 was adjusted for menopausal status and concurrent use of menopausal hormone therapy.

c

Model 2 was adjusted for model 1 plus following socio-demographic and lifestyle factors: race/ethnicity, education, smoking status, and BMI. Data for SWAN were additionally adjusted for study site.